Literature DB >> 22011620

Respiratory impairment and mortality in older persons: a novel spirometric approach.

Carlos A Vaz Fragoso1, Thomas M Gill, Gail McAvay, Henry Klar Yaggi, Peter H Van Ness, John Concato.   

Abstract

BACKGROUND: The Lambda-Mu-Sigma (LMS) method calculates the lower limit of normal for spirometric measures of pulmonary function as the fifth percentile of the distribution of z scores, suitably accounting for age-related changes in pulmonary function. Extending prior work, and to assess whether the LMS method is clinically valid when evaluating respiratory impairment in the elderly, our current objective was to evaluate the association of LMS-defined respiratory impairment (airflow limitation and restrictive pattern) with all-cause mortality and respiratory symptoms (chronic bronchitis, dyspnea, or wheezing) in older persons.
METHODS: Spirometric data and outcome data on white participants aged 65 to 80 years were obtained from the Third National Health and Nutrition Examination Survey (NHANES-III, n = 1497) and the Cardiovascular Health Study (CHS, n = 3583). Multivariable analyses determined the corresponding associations, adjusting for important covariates.
RESULTS: In the NHANES-III and CHS populations, respectively, LMS-defined airflow limitation had adjusted hazard ratios (95% confidence interval) of 1.64 (1.28-2.11) and 1.69 (1.48-1.92) for mortality; adjusted odds ratios for respiratory symptoms were 2.71 (1.92-3.83) and 2.63 (2.11-3.27). The LMS-defined restrictive pattern was also significantly associated with mortality (adjusted hazard ratios of 1.98 [1.54-2.53] and 1.68 [1.44-1.95]), as well as with respiratory symptoms (adjusted odds ratios of 1.55 [1.03-2.34] and 1.37 [1.07-1.75]) in NHANES-III and CHS, respectively.
CONCLUSIONS: The LMS-defined airflow limitation and restrictive pattern confers a significantly increased risk of death and likelihood of having respiratory symptoms. These results support the use of LMS-derived spirometric z scores as a basis for evaluating respiratory impairment in older persons.

Entities:  

Mesh:

Year:  2011        PMID: 22011620      PMCID: PMC3198012          DOI: 10.2310/JIM.0b013e31822bb213

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


  33 in total

1.  Short-term variation in air pollution and in average lung function among never-smokers. The Swiss Study on Air Pollution and Lung Diseases in Adults (SAPALDIA).

Authors:  C Schindler; N Künzli; J P Bongard; P Leuenberger; W Karrer; R Rapp; C Monn; U Ackermann-Liebrich
Journal:  Am J Respir Crit Care Med       Date:  2001-02       Impact factor: 21.405

Review 2.  Airway hyperresponsiveness and COPD mortality.

Authors:  J Vestbo; E F Hansen
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

3.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.

Authors:  B R Celli; W MacNee
Journal:  Eur Respir J       Date:  2004-06       Impact factor: 16.671

4.  Spirometric reference equations for European females and males aged 65-85 yrs.

Authors:  F García-Río; J M Pino; A Dorgham; A Alonso; J Villamor
Journal:  Eur Respir J       Date:  2004-09       Impact factor: 16.671

5.  Performance evaluation of contemporary spirometers.

Authors:  S B Nelson; R M Gardner; R O Crapo; R L Jensen
Journal:  Chest       Date:  1990-02       Impact factor: 9.410

6.  Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society.

Authors: 
Journal:  Am Rev Respir Dis       Date:  1991-11

7.  Spirometric reference values from a sample of the general U.S. population.

Authors:  J L Hankinson; J R Odencrantz; K B Fedan
Journal:  Am J Respir Crit Care Med       Date:  1999-01       Impact factor: 21.405

8.  Evidence-based health policy--lessons from the Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

Review 9.  Clinical use of bone densitometry: scientific review.

Authors:  Steven R Cummings; David Bates; Dennis M Black
Journal:  JAMA       Date:  2002-10-16       Impact factor: 56.272

10.  A spirometry-based algorithm to direct lung function testing in the pulmonary function laboratory.

Authors:  Christine A Glady; Shawn D Aaron; Mary Lunau; Jennifer Clinch; Robert E Dales
Journal:  Chest       Date:  2003-06       Impact factor: 9.410

View more
  16 in total

1.  Imaging Features of Chronic Bronchitis with Preserved Ratio and Impaired Spirometry (PRISm).

Authors:  Xia Wei; Qi Ding; Nan Yu; Jiuyun Mi; Jingting Ren; Jie Li; Shudi Xu; Yanzhong Gao; Youmin Guo
Journal:  Lung       Date:  2018-09-14       Impact factor: 2.584

2.  Respiratory impairment and dyspnea and their associations with physical inactivity and mobility in sedentary community-dwelling older persons.

Authors:  Carlos A Vaz Fragoso; Daniel P Beavers; John L Hankinson; Gail Flynn; Kathy Berra; Stephen B Kritchevsky; Christine K Liu; Mary M McDermott; Todd M Manini; W Jack Rejeski; Thomas M Gill
Journal:  J Am Geriatr Soc       Date:  2014-03-17       Impact factor: 5.562

3.  Respiratory impairment and COPD hospitalisation in older persons: a competing risk analysis.

Authors:  Carlos A Vaz Fragoso; John Concato; Gail McAvay; Peter H Van Ness; Thomas M Gill
Journal:  Eur Respir J       Date:  2012-01-20       Impact factor: 16.671

Review 4.  Respiratory impairment and the aging lung: a novel paradigm for assessing pulmonary function.

Authors:  Carlos A Vaz Fragoso; Thomas M Gill
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-12-01       Impact factor: 6.053

Review 5.  Epidemiology of Chronic Obstructive Pulmonary Disease (COPD) in Aging Populations.

Authors:  Carlos A Vaz Fragoso
Journal:  COPD       Date:  2015-12-02       Impact factor: 2.409

6.  Phenotype of normal spirometry in an aging population.

Authors:  Carlos A Vaz Fragoso; Gail McAvay; Peter H Van Ness; Richard Casaburi; Robert L Jensen; Neil MacIntyre; Thomas M Gill; H Klar Yaggi; John Concato
Journal:  Am J Respir Crit Care Med       Date:  2015-10-01       Impact factor: 21.405

7.  Effect of coexisting chronic obstructive pulmonary disease and cognitive impairment on health outcomes in older adults.

Authors:  Sandy S Chang; Shu Chen; Gail J McAvay; Mary E Tinetti
Journal:  J Am Geriatr Soc       Date:  2012-10-04       Impact factor: 5.562

8.  Ethnic differences in respiratory impairment.

Authors:  Carlos A Vaz Fragoso; Gail McAvay; Thomas M Gill; John Concato; Philip H Quanjer; Peter H Van Ness
Journal:  Thorax       Date:  2013-08-12       Impact factor: 9.139

9.  Respiratory impairment in older persons: when less means more.

Authors:  Carlos A Vaz Fragoso; Thomas M Gill; Gail McAvay; Philip H Quanjer; Peter H Van Ness; John Concato
Journal:  Am J Med       Date:  2012-11-20       Impact factor: 4.965

10.  COPDGene® 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease.

Authors:  Katherine E Lowe; Elizabeth A Regan; Antonio Anzueto; Erin Austin; John H M Austin; Terri H Beaty; Panayiotis V Benos; Christopher J Benway; Surya P Bhatt; Eugene R Bleecker; Sandeep Bodduluri; Jessica Bon; Aladin M Boriek; Adel Re Boueiz; Russell P Bowler; Matthew Budoff; Richard Casaburi; Peter J Castaldi; Jean-Paul Charbonnier; Michael H Cho; Alejandro Comellas; Douglas Conrad; Corinne Costa Davis; Gerard J Criner; Douglas Curran-Everett; Jeffrey L Curtis; Dawn L DeMeo; Alejandro A Diaz; Mark T Dransfield; Jennifer G Dy; Ashraf Fawzy; Margaret Fleming; Eric L Flenaugh; Marilyn G Foreman; Spyridon Fortis; Hirut Gebrekristos; Sarah Grant; Philippe A Grenier; Tian Gu; Abhya Gupta; MeiLan K Han; Nicola A Hanania; Nadia N Hansel; Lystra P Hayden; Craig P Hersh; Brian D Hobbs; Eric A Hoffman; James C Hogg; John E Hokanson; Karin F Hoth; Albert Hsiao; Stephen Humphries; Kathleen Jacobs; Francine L Jacobson; Ella A Kazerooni; Victor Kim; Woo Jin Kim; Gregory L Kinney; Harald Koegler; Sharon M Lutz; David A Lynch; Neil R MacIntye; Barry J Make; Nathaniel Marchetti; Fernando J Martinez; Diego J Maselli; Anne M Mathews; Meredith C McCormack; Merry-Lynn N McDonald; Charlene E McEvoy; Matthew Moll; Sarah S Molye; Susan Murray; Hrudaya Nath; John D Newell; Mariaelena Occhipinti; Matteo Paoletti; Trisha Parekh; Massimo Pistolesi; Katherine A Pratte; Nirupama Putcha; Margaret Ragland; Joseph M Reinhardt; Stephen I Rennard; Richard A Rosiello; James C Ross; Harry B Rossiter; Ingo Ruczinski; Raul San Jose Estepar; Frank C Sciurba; Jessica C Sieren; Harjinder Singh; Xavier Soler; Robert M Steiner; Matthew J Strand; William W Stringer; Ruth Tal-Singer; Byron Thomashow; Gonzalo Vegas Sánchez-Ferrero; John W Walsh; Emily S Wan; George R Washko; J Michael Wells; Chris H Wendt; Gloria Westney; Ava Wilson; Robert A Wise; Andrew Yen; Kendra Young; Jeong Yun; Edwin K Silverman; James D Crapo
Journal:  Chronic Obstr Pulm Dis       Date:  2019-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.